Literature DB >> 1436522

Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis.

G J Dal Pan1, J H McArthur, E Aylward, O A Selnes, T E Nance-Sproson, A J Kumar, E D Mellits, J C McArthur.   

Abstract

Cerebral atrophy is a common radiologic manifestation of HIV dementia. To evaluate the relationship between cognitive impairment and cerebral atrophy, adjusting for age and immune status, we used standardized planimetry to measure the ventricle-brain ratio (VBR) and the bifrontal (BFR) and bicaudate (BCR) ratios, three measures of cerebral atrophy. We analyzed cranial MRIs of 23 HIV-1-seronegative controls (SN) and 116 HIV-1-infected individuals. Of the HIV-1-seropositive individuals, 37 had HIV dementia (DM group), 40 had neurologic or neuropsychological abnormalities insufficient for HIV dementia (NP+ group), and 39 were neurologically normal (NML group). We performed comparisons using analysis of covariance with correction for multiple comparisons. Both the VBR, a general measure of overall cerebral atrophy, and the BCR, a measure of atrophy in the region of the caudate nucleus, are significantly associated with dementia. The association is stronger for BCR enlargement than for VBR enlargement, suggesting that selective caudate region atrophy is associated with HIV dementia. These results indicate that overall cerebral atrophy and prominent caudate region atrophy are important radiographic features of HIV dementia.

Entities:  

Mesh:

Year:  1992        PMID: 1436522     DOI: 10.1212/wnl.42.11.2125

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Reward, attention, and HIV-related risk in HIV+ individuals.

Authors:  Brian A Anderson; Sharif I Kronemer; Jessica J Rilee; Ned Sacktor; Cherie L Marvel
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

3.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.

Authors:  V A Cardenas; D J Meyerhoff; C Studholme; J Kornak; J Rothlind; H Lampiris; J Neuhaus; R M Grant; L L Chao; D Truran; M W Weiner
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

Review 4.  Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.

Authors:  Italo Mocchetti; Alessia Bachis; Lee A Campbell; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-06       Impact factor: 4.147

5.  Quantitative MRI Measures in SIV-Infected Macaque Brains.

Authors:  Xiaodong Zhang; Chunxia Li
Journal:  J Clin Cell Immunol       Date:  2013

6.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Authors:  I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

7.  Correlation of MRI and neuropathology in AIDS.

Authors:  I P Everall; W K Chong; I D Wilkinson; M N Paley; R J Chinn; M A Hall-Craggs; F Scaravilli; P L Lantos; P J Luthert; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

8.  Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.

Authors:  Elham Rahimy; Fang-Yong Li; Lars Hagberg; Dietmar Fuchs; Kevin Robertson; Dieter J Meyerhoff; Henrik Zetterberg; Richard W Price; Magnus Gisslén; Serena Spudich
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

9.  Spatial data analysis in the quantitative assessment of cerebral white matter pathology on MRI in HIV infection.

Authors:  R J Corrigall; W K Chong; M Paley; I D Wilkinson; P Lantos; I Everall
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

10.  Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.

Authors:  Robert H Paul; Thomas Ernst; Adam M Brickman; Constantin T Yiannoutsos; David F Tate; Ronald A Cohen; Bradford A Navia
Journal:  J Int Neuropsychol Soc       Date:  2008-09       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.